RxSight (RXST) EBT Margin (2020 - 2026)
RxSight (RXST) posted EBT Margin of 51.4% for Q1 2026, down 83.22% on a QoQ basis from 28.05% in Q4 2025, and down 2983.0% year-over-year from 1.78% in Q1 2025.
RxSight (RXST) EBT Margin (2020 - 2026) Analysis & Trends
RxSight's EBT Margin history runs 7 years deep, the most recent figure standing at 51.4% for Q1 2026.
- Quarterly EBT Margin fell 2983.0% year-over-year to 51.4% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.54% (down 1869.0% YoY) and the FY2025 annual result came in at 28.91%, down 932.0% from the prior year.
- EBT Margin was 51.4% for Q1 2026 at RxSight, down from 28.05% in the prior quarter.
- Across five years, EBT Margin topped out at 317.91% in Q4 2022 and bottomed at 196.73% in Q1 2022.
- A 5-year average of 27.55% and a median of 32.32% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin surged 50462 bps — and 2023, when it plunged 18007 bps.
- RxSight's EBT Margin stood at 317.91% in 2022, then sank by 57 bps to 137.84% in 2023, then sank by 111 bps to 14.74% in 2024, then sank by 90 bps to 28.05% in 2025, then slumped by 83 bps to 51.4% in 2026.
- Business Quant data shows RXST's EBT Margin at 51.4% in Q1 2026, 28.05% in Q4 2025, and 32.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -51.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.40% |
| Dec 31, 2025 | -28.05% |
| Sep 30, 2025 | -32.32% |
| Jun 30, 2025 | -34.94% |
| Mar 31, 2025 | -21.56% |
| Dec 31, 2024 | -14.74% |
| Sep 30, 2024 | -17.91% |
| Jun 30, 2024 | -17.38% |
| Mar 31, 2024 | -30.80% |
| Dec 31, 2023 | 137.84% |
| Sep 30, 2023 | -55.87% |
| Jun 30, 2023 | -66.21% |
| Mar 31, 2023 | -75.54% |
| Dec 31, 2022 | 317.91% |
| Sep 30, 2022 | -133.32% |
| Jun 30, 2022 | -147.29% |
| Mar 31, 2022 | -196.73% |
| Dec 31, 2021 | -186.71% |
| Sep 30, 2021 | -219.10% |
| Jun 30, 2021 | -275.15% |